Key Facts
- CAS
- โ
- Molecular Weight (MW)
- 3367.8 g/mol
- Half-life
- ~8 hours
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- 1ร daily
- Last updated
- 2/17/2026
- Targets
- GHRH receptor
Overview
โ
Protocol
- Dosage Range
- 1โ2 mg per injection
- Frequency
- 1ร daily
- Cycle
- 8โ12 weeks on / 4 weeks off
- Administration Route
- Subcutaneous
- Reconstitution Guide
- Add 2 mL bacteriostatic water per 2 mg vial.
Science
Mechanism of Action
Stimulates pituitary GH release via cAMP pathway.
Targets
GHRH receptor
Studies
- โ Journal/year not available
Benefits
Increased GH releaseImproved sleepMuscle growthFat loss
Potential Side Effects
- Flushing
- Water retention
- Joint stiffness
References
- PMID: 16728527External link ยท Year โ